Association of Hippo Signalling Pathway with Epigenetic Changes in Cancer Cells and Therapeutic Approaches: A Review.

Motavalli, Roza; Marofi, Faroogh; Nasimi, Maryam; Yousefi, Mehdi; Khiavi, Farhad M

Motavalli, Roza; Marofi, Faroogh; Nasimi, Maryam; Yousefi, Mehdi; Khiavi, Farhad M.

Affiliation

Motavalli R; Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Marofi F; Department of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Nasimi M; Department of Dermatology, Tehran University of Medical Sciences, Tehran, Iran.
Yousefi M; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Khiavi FM; Department of Virology, Pasteur Institute of Iran, Tehran, Iran.

Anticancer Agents Med Chem ; 21(12): 1520-1528, 2021.

Article in En | MEDLINE | ID: mdl-33121418

Subject(s)

Antineoplastic Agents/pharmacology; Neoplasms/drug therapy; Antineoplastic Agents/chemistry; Epigenesis, Genetic/drug effects; Epigenesis, Genetic/genetics; Hippo Signaling Pathway/drug effects; Humans; Neoplasms/genetics; Neoplasms/metabolism

Key words

DNA methylation; HDACs; Hippo signalling; cancer cell; lncRNA; tissue regeneration

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Neoplasms / Antineoplastic Agents Type of study: Risk_factors_studies Language: En Journal: Anticancer Agents Med Chem Year: 2021 Type: Article Affiliation country: Iran

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google